The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Efficacy and Safety of Bacille Calmette-Guérin Immunotherapy in Superficial Bladder Cancer
Abstract
In the United States, bladder cancer is the fourth most common human malignancy. In the past decade, the incidence of bladder cancer has increased by 36%. However, mortality has declined by 8%. Intravesical chemotherapy was considered to be partially responsible for this improvement in survival, but a recent review of clinical studies shows no reduction in disease progression with intravesical chemotherapy. Fortunately, the results of immunotherapy with bacille Calmette-Guérin (BCG) are quite different, and it is expected that patients treated with optimal BCG treatment regimens will have a long-term reduction in tumor recurrence, tumor progression, and cancer mortality.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Intracavitary Bacillus Calmette-guerin in the Treatment of Superficial Bladder Tumors
Morales, A., Eidinger, D., & Bruce, A. W. (1976) · Journal of Urology · doi:10.1016/s0022-5347(17)58737-6 · Cited by 1,791
Intracavitary Bacillus Calmette-Guerin in the Treatment of Superficial Bladder Tumors
Morales, A., Eidinger, D., & Bruce, A. W. (2017) · Journal of Urology · doi:10.1016/j.juro.2016.10.101 · Cited by 1,533
Intracavitary bacillus Calmette-Grerin in the treatement of superficial bladder tumors
Morales, A. (1976) · The Journal of Urology · Cited by 978
Lamm, D. L., Van Der Meijden, A. P. M., Morales, A., Brosman, S. A., Catalona, W. J., Herr, H. W., Soloway, M. S., Steg, A., & Debruyne, F. M. J. (1992) · Journal of Urology · doi:10.1016/s0022-5347(17)37316-0 · Cited by 786
Self-citationLamm, D. L., Blumenstein, B. A., Crawford, E. D., Montie, J. E., Scardino, P., Grossman, H. B., Stanisic, T. H., Smith, J. A., Sullivan, J., Sarosdy, M. F., et al. (1991) · New England Journal of Medicine · doi:10.1056/nejm199110243251703 · Cited by 605
Self-citationLONG-TERM RESULTS OF INTRAVESICAL THERAPY FOR SUPERFICIAL BLADDER CANCER
Lamm, D. L. (1992) · Urologic Clinics of North America · doi:10.1016/s0094-0143(21)00424-9 · Cited by 273
Self-citationKrege, S., Giani, G., Meyer, R., Otto, T., & Rubben, H. (1996) · Journal of Urology · doi:10.1016/s0022-5347(01)65673-8 · Cited by 195
A Low Dose Bacillus Calmette-Guerin Regimen in Superficial Bladder Cancer Therapy: Is it Effective?
Pagano, F., Bassi, P., Milani, C., Meneghini, A., Maruzzi, D., & Garbeglio, A. (1991) · Journal of Urology · doi:10.1016/s0022-5347(17)37707-8 · Cited by 170
Comparison of BCG with other intravesical agents
Lamm, D. L. (1991) · Urology · doi:10.1016/0090-4295(91)80136-u · Cited by 18
Self-citation
Cited by
Tumor microenvironment targeted nanotherapeutics for cancer therapy and diagnosis: A review
Thakkar, S., Sharma, D., Kalia, K., & Tekade, R. K. (2020) · Acta Biomaterialia · doi:10.1016/j.actbio.2019.09.009 · Cited by 316
Mohammed, A., & Arastu, Z. (2017) · BMC Urology · doi:10.1186/s12894-017-0304-5 · Cited by 20
Acute granulomatous tubulointerstitial nephritis caused by intravesical BCG
Kennedy, S. E., Shrikanth, S., & Charlesworth, J. A. (2006) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfk071 · Cited by 17
Acute renal failure due to interstitial nephritis after intravesical instillation of BCG
Jose Manzanera Escribano, M., Morales Ruiz, E., Odriozola Grijalba, M., Gutierrez Martínez, E., Rodriguez Antolín, A., & Praga Terente, M. (2007) · Clinical and Experimental Nephrology · doi:10.1007/s10157-007-0483-6 · Cited by 16
Intravesical BCG instillation as a possible cause of acute and chronic kidney injury
Tamzali, Y., Jamme, M., Bottet, F., Gauthe, M., Rondeau, E., Pialoux, G., & Calin, R. (2021) · Infectious Diseases Now · doi:10.1016/j.medmal.2020.09.009 · Cited by 3
Metadata
- Authors
- Lamm, D. L.
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2000-09-01
- Volume
- 31
- Issue
- Supplement_3
- Pages
- S86-S90
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W1970681090
- Cited by
- 264
- References
- 9
- FWCI
- 5.46
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.